BA

Boobala Arjunamurthy

Director DIN 08256169
DIN 08256169 First appointment Oct 2018
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Boobala Arjunamurthy

Data last updated:

Boobala Arjunamurthy was a Director at Liliebon Healthcare Private Limited (from 2018) and Director at Arjunra Mentor Private Limited (from 2022).

DIN 08256169
First Appointment 12 Oct 2018
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Liliebon Healthcare Private Limited U74999TN2018PTC125245
Director12 Oct 20182018Strike Off
Arjunra Mentor Private Limited U74999TN2022PTC150149
Director22 Feb 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Liliebon Healthcare Private Limited
Arjunra Mentor Private Limited
Premium access

Shareholding and investment profile for Boobala Arjunamurthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Boobala Arjunamurthy

Boobala Arjunamurthy was first appointed on 12 Oct 2018 as Director at Liliebon Healthcare Private Limited. The most recent appointment on record is 22 Feb 2022 at Arjunra Mentor Private Limited.

Boobala Arjunamurthy held 2 earlier board appointments: Liliebon Healthcare Private Limited (Director, from 12 Oct 2018); Arjunra Mentor Private Limited (Director, from 22 Feb 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available